£145.51

Springer Phosphoinositide 3-kinase in Health and Disease: Volume 2: 347 (Current Topics in Microbiology and Immunology, 347)

Price data last checked 44 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 47 days • 47 data points (No recent data available)

Historical
Generating forecast...
£146.24 £141.41 £142.46 £143.52 £144.57 £145.63 £146.68 25 January 2026 05 February 2026 17 February 2026 28 February 2026 12 March 2026

Price Distribution

Price distribution over 47 days • 3 price levels

Days at Price
Current Price
9 days 11 days · current 27 days 0 7 14 20 27 £142 £146 £146 Days at Price

Price Analysis

Most common price: £146 (27 days, 57.4%)

Price range: £142 - £146

Price levels: 3 different prices over 47 days

Description

Product Description PI3K has become a very intense area of research, with over 2000 publications on PI3K in PubMed for 2009 alone. The expectations for a therapeutic impact of intervention with PI3K activity are high, and progress in the clinical arena is being monitored by many. However, targeted therapies almost invariably encounter roadblocks, often exposing unresolved questions in the basic understanding of the target From the Back Cover From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Phosphoinositide 3-kinase in Health and Disease: Volume 2: 347 (Current Topics in Microbiology and Immunology, 347)
99% match

Phosphoinositide 3-kinase in Health and Disease: Volume 2: 347 (Current Topics in Microbiology and Immunology, 347)

Springer

£139.50 12 Dec 2025
Phosphoinositide 3-kinase in Health and Disease: Volume 1: 346 (Current Topics in Microbiology and Immunology, 346)
98% match

Phosphoinositide 3-kinase in Health and Disease: Volume 1: 346 (Current Topics in Microbiology and Immunology, 346)

Springer

£146.56 07 Mar 2026
Phosphoinositide 3-kinase in Health and Disease: Volume 1: 346 (Current Topics in Microbiology and Immunology, 346)
98% match

Phosphoinositide 3-kinase in Health and Disease: Volume 1: 346 (Current Topics in Microbiology and Immunology, 346)

Springer

£146.56 10 Mar 2026
Academic Press Protein Kinase Inhibitors: Discovery to Therapeutics
93% match

Academic Press Protein Kinase Inhibitors: Discovery to Therapeutics

Academic Press

£115.89 28 Feb 2026
Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites
93% match

Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

Springer

£91.63 09 Mar 2026
Springer Complement Therapeutics: 735 - Medical Research Book
92% match

Springer Complement Therapeutics: 735 - Medical Research Book

Springer

£111.14 01 Mar 2026
Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites
92% match

Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

Springer

£91.28 05 Mar 2026
Therapeutic Kinase Inhibitors: 355 (Current Topics in Microbiology and Immunology, 355)
92% match

Therapeutic Kinase Inhibitors: 355 (Current Topics in Microbiology and Immunology, 355)

Springer

£107.43 09 Mar 2026
Phosphoinositides I: Enzymes of Synthesis and Degradation: 58 (Subcellular Biochemistry, 58)
92% match

Phosphoinositides I: Enzymes of Synthesis and Degradation: 58 (Subcellular Biochemistry, 58)

Springer

£90.71 22 Feb 2026
Phosphoinositides in Subcellular Targeting and Enzyme Activation: 282 (Current Topics in Microbiology and Immunology)
92% match

Phosphoinositides in Subcellular Targeting and Enzyme Activation: 282 (Current Topics in Microbiology and Immunology)

Springer

Out of Stock 01 Mar 2026
Protein Kinase Protocols: 124 (Methods in Molecular Biology, 124)
92% match

Protein Kinase Protocols: 124 (Methods in Molecular Biology, 124)

Humana

£74.26 07 Mar 2026
TAM Receptors in Health and Disease: Volume 357 (International Review of Cell and Molecular Biology, Volume 357)
91% match

TAM Receptors in Health and Disease: Volume 357 (International Review of Cell and Molecular Biology, Volume 357)

Academic Press

£148.98 22 Jan 2026
Protein Kinase Protocols: 124 (Methods in Molecular Biology, 124)
91% match

Protein Kinase Protocols: 124 (Methods in Molecular Biology, 124)

Humana

£44.10 08 Mar 2026
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
91% match

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Springer

£119.08 18 Apr 2026
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
91% match

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Springer

£126.23 08 Feb 2026
Phosphoinositides II: The Diverse Biological Functions: 59 (Subcellular Biochemistry, 59)
91% match

Phosphoinositides II: The Diverse Biological Functions: 59 (Subcellular Biochemistry, 59)

Springer

£143.38 13 Apr 2026
Humana PI3K-mTOR in Cancer and Cancer Therapy Book
91% match

Humana PI3K-mTOR in Cancer and Cancer Therapy Book

Humana

£109.96 02 Mar 2026
Springer Phosphoinositides I: Enzymes of Synthesis and Degradation
91% match

Springer Phosphoinositides I: Enzymes of Synthesis and Degradation

Springer

£93.55 19 Apr 2026
Pharmacology of Immunotherapeutic Drugs
91% match

Pharmacology of Immunotherapeutic Drugs

Springer

£96.18 11 Jan 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
91% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
91% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Springer - The p53 Tumor Suppressor Pathway and Cancer 2
91% match

Springer - The p53 Tumor Suppressor Pathway and Cancer 2

Springer

£107.43 01 Mar 2026
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases (Progress in Inflammation Research)
91% match

Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases (Progress in Inflammation Research)

Springer

£107.85 09 Mar 2026
Immunopharmacology
91% match

Immunopharmacology

Springer

£92.56 26 Feb 2026